1. Home
  2. HURA vs SEVN Comparison

HURA vs SEVN Comparison

Compare HURA & SEVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HURA
  • SEVN
  • Stock Information
  • Founded
  • HURA 2009
  • SEVN 1986
  • Country
  • HURA United States
  • SEVN United States
  • Employees
  • HURA N/A
  • SEVN N/A
  • Industry
  • HURA
  • SEVN Real Estate Investment Trusts
  • Sector
  • HURA
  • SEVN Real Estate
  • Exchange
  • HURA Nasdaq
  • SEVN Nasdaq
  • Market Cap
  • HURA 171.7M
  • SEVN 173.7M
  • IPO Year
  • HURA N/A
  • SEVN N/A
  • Fundamental
  • Price
  • HURA $2.72
  • SEVN $11.95
  • Analyst Decision
  • HURA Strong Buy
  • SEVN Strong Buy
  • Analyst Count
  • HURA 2
  • SEVN 4
  • Target Price
  • HURA $11.50
  • SEVN $14.50
  • AVG Volume (30 Days)
  • HURA 132.5K
  • SEVN 38.2K
  • Earning Date
  • HURA 06-17-2025
  • SEVN 07-28-2025
  • Dividend Yield
  • HURA N/A
  • SEVN 11.67%
  • EPS Growth
  • HURA N/A
  • SEVN N/A
  • EPS
  • HURA N/A
  • SEVN 1.15
  • Revenue
  • HURA N/A
  • SEVN $30,074,000.00
  • Revenue This Year
  • HURA N/A
  • SEVN $7.45
  • Revenue Next Year
  • HURA $69.15
  • SEVN $1.12
  • P/E Ratio
  • HURA N/A
  • SEVN $10.35
  • Revenue Growth
  • HURA N/A
  • SEVN N/A
  • 52 Week Low
  • HURA $1.80
  • SEVN $10.18
  • 52 Week High
  • HURA $13.13
  • SEVN $14.66
  • Technical
  • Relative Strength Index (RSI)
  • HURA N/A
  • SEVN 49.95
  • Support Level
  • HURA N/A
  • SEVN $11.63
  • Resistance Level
  • HURA N/A
  • SEVN $11.99
  • Average True Range (ATR)
  • HURA 0.00
  • SEVN 0.35
  • MACD
  • HURA 0.00
  • SEVN 0.01
  • Stochastic Oscillator
  • HURA 0.00
  • SEVN 57.58

About HURA TuHURA Biosciences Inc. Common Stock

TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.

About SEVN Seven Hills Realty Trust

Seven Hills Realty Trust is a real estate investment trust. The company is engaged in the business of originating and investing in floating rate first mortgage loans secured by the middle market and transitional commercial real estate. Its primary objective is to balance capital preservation with generating risk-adjusted returns.

Share on Social Networks: